Inflation Reduction Act foes race to repeal climate, drug pricing programs

When President Biden signed his sprawling economic spending package into law last August, he heralded its massive investments in health care and climate change as an achievement that defied the odds.

“The American people won, and the special interests lost,” Biden proclaimed at the time.

Nearly a year later, though, his pronouncement appears in jeopardy: A growing roster of corporate and political foes has started to lay siege to the law known as the Inflation Reduction Act, hoping to erode some of its key provisions before they can take effect.